CVEvulnerability

CVE-2026-41360

5.4 MEDIUM Published 2026-04-23 Modified 2026-06-17 Official page ↗
Status
Analyzed
Published
2026-04-23
Last modified
2026-06-17
Assigner
[email protected]
CVSS 4.0 ([email protected])
5.4 MEDIUM — CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
6.7 MEDIUM — CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
Weaknesses
CWE-367

Description

OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.

Affected configurations

• openclaw openclaw (< 2026.4.2)

Related

Weakness · CWE (1)

  • CWE-367 Time-of-check Time-of-use (TOCTOU) Race Condition weakness

References